116 related articles for article (PubMed ID: 32898013)
21. HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review.
Wu T; Zhang W; Yang G; Li H; Chen Q; Song R; Zhao L
Oncotarget; 2016 Aug; 7(31):50417-50427. PubMed ID: 27391431
[TBL] [Abstract][Full Text] [Related]
22. [Expression and clinical significance of HMGA2 in renal carcinoma].
Liu Y; Fu QZ; Pu L; Song LL; Lyu GY; Liu J; Wang Z; Wang Z
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):127-132. PubMed ID: 28219208
[No Abstract] [Full Text] [Related]
23. The utility of high-mobility group A2 overexpression for predicting the prognosis of gastric cancer patients and its contribution to poor prognosis via chemoresistance and the propensity for the occurrence of carcinomatosis peritonei.
Lee H; Lee HH; Lim CY; Lee J
Surgery; 2021 May; 169(5):1213-1220. PubMed ID: 33376002
[TBL] [Abstract][Full Text] [Related]
24. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
25. Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis.
Sun S; Dong H; Yan T; Li J; Liu B; Shao P; Li J; Liang C
BMC Med Genet; 2020 Jun; 21(1):139. PubMed ID: 32600280
[TBL] [Abstract][Full Text] [Related]
26. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas.
Liu B; Pang B; Hou X; Fan H; Liang N; Zheng S; Feng B; Liu W; Guo H; Xu S; Pang Q
Hum Pathol; 2014 Aug; 45(8):1752-8. PubMed ID: 24935062
[TBL] [Abstract][Full Text] [Related]
27. MiR-142-3p targets HMGA2 and suppresses breast cancer malignancy.
Mansoori B; Duijf PHG; Mohammadi A; Safarzadeh E; Ditzel HJ; Gjerstorff MF; Cho WC; Baradaran B
Life Sci; 2021 Jul; 276():119431. PubMed ID: 33785332
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
29. [Overexpression of high mobility group A2 and its correlation with microRNA let-7 family in serous ovarian cancers].
Yang J; Zhang Q; Dong JQ; Chang XH; He XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):749-54. PubMed ID: 23073586
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of the MDM2/HMGA2 ratio and histological tumor grade in dedifferentiated liposarcoma.
Yamashita K; Kohashi K; Yamada Y; Akatsuka S; Ikuta K; Nishida Y; Toyokuni S; Oda Y
Genes Chromosomes Cancer; 2021 Jan; 60(1):26-37. PubMed ID: 33111425
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis HMGA2 as a prognostic marker of bladder cancer.
Yang GL; Zhang LH; Bo JJ; Hou KL; Cai X; Chen YY; Li H; Liu DM; Huang YR
Eur J Surg Oncol; 2011 Mar; 37(3):265-71. PubMed ID: 21273026
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and significance of HMGA2 expression in oesophageal adenocarcinoma.
Mito JK; Agoston AT; Dal Cin P; Srivastava A
Histopathology; 2017 Dec; 71(6):909-917. PubMed ID: 28710822
[TBL] [Abstract][Full Text] [Related]
34. Significance of HMGA2 expression as independent poor prognostic marker in perihilar and distal cholangiocarcinoma resected with curative intent.
Takahashi T; Kawaji H; Murakawa Y; Hayashizaki Y; Murakami T; Yabushita Y; Homma Y; Kumamoto T; Matsuyama R; Endo I
Eur J Surg Oncol; 2021 Feb; 47(2):394-400. PubMed ID: 32878723
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
Liu TP; Huang CC; Yeh KT; Ke TW; Wei PL; Yang JR; Cheng YW
Surg Oncol; 2016 Dec; 25(4):429-434. PubMed ID: 27262492
[TBL] [Abstract][Full Text] [Related]
36. HMGA2 Gene Expression in Fine-needle Aspiration Samples of Thyroid Nodules as a Marker for Preoperative Diagnosis of Thyroid Cancer.
Šamija I; Mateša N; Kožaj S; Majstorović I; Bolanča A; Kusić Z
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):471-476. PubMed ID: 29406334
[TBL] [Abstract][Full Text] [Related]
37. Oncological role of HMGA2 (Review).
Zhang S; Mo Q; Wang X
Int J Oncol; 2019 Oct; 55(4):775-788. PubMed ID: 31432151
[TBL] [Abstract][Full Text] [Related]
38. The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis.
Li JZ; Gao W; Ho WK; Lei WB; Wei WI; Chan JY; Wong TS
Chin J Cancer; 2016 Nov; 35(1):95. PubMed ID: 27852288
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Role of Tenascin-C for Cancer Outcome: A Meta-Analysis.
Ming X; Qiu S; Liu X; Li S; Wang Y; Zhu M; Li N; Luo P; Liang C; Tu J
Technol Cancer Res Treat; 2019 Jan; 18():1533033818821106. PubMed ID: 30803361
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of periostin in multiple solid cancers: A systematic review with meta-analysis.
Yang T; Deng Z; Pan Z; Qian Y; Yao W; Wang J
J Cell Physiol; 2020 Mar; 235(3):2800-2808. PubMed ID: 31517399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]